Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, July 28, 2017
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
Thu, July 27, 2017
[ Thu, Jul 27th 2017
] - WOPRAI
[ Thu, Jul 27th 2017
] - WOPRAI
[ Thu, Jul 27th 2017
] - WOPRAI
[ Thu, Jul 27th 2017
] - WOPRAI
[ Thu, Jul 27th 2017
] - WOPRAI
[ Thu, Jul 27th 2017
] - WOPRAI
[ Thu, Jul 27th 2017
] - WOPRAI
[ Thu, Jul 27th 2017
] - WOPRAI
[ Thu, Jul 27th 2017
] - WOPRAI
[ Thu, Jul 27th 2017
] - WOPRAI
Wed, July 26, 2017
[ Wed, Jul 26th 2017
] - WOPRAI
Carter Gould Maintained (BIIB) at Hold with Increased Target to $285 on, Jul 26th, 2017
Carter Gould of UBS, Maintained "Biogen Inc." (BIIB) at Hold with Increased Target from $270 to $285 on, Jul 26th, 2017.
Carter has made no other calls on BIIB in the last 4 months.
There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 1 agrees with Carter's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Eun Yang of "Jefferies" Initiated at Hold and Held Target at $310 on, Tuesday, July 11th, 2017
This is the rating of the analyst that currently disagrees with Carter
- Andrew Peters of "Deutsche Bank" Initiated at Strong Buy and Held Target at $315 on, Friday, June 23rd, 2017
Similar Stocks and Investing Articles
[ Mon, Jul 17th 2017
] - WOPRAI
[ Tue, Jul 11th 2017
] - WOPRAI
[ Mon, Jul 10th 2017
] - WOPRAI
[ Wed, Jul 15th 2015
] - WOPRAI
[ Wed, Jul 09th 2014
] - WOPRAI
[ Tue, Jul 01st 2014
] - WOPRAI
[ Tue, Jul 01st 2014
] - WOPRAI
[ Tue, Jul 23rd 2013
] - WOPRAI
[ Thu, Sep 27th 2012
] - WOPRAI